| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239438 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 9 Pages |
Abstract
Survivin appears to be a molecular biomarker in patients with rectal cancer. Furthermore, in vitro and in vivo data suggest a potential role of survivin as a molecular target to improve treatment response to radiotherapy in patients with rectal cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Franz Ph.D., Benjamin Ph.D., Werner M.S., Gianni Ph.D., Christian M.D., Claus M.D.,